Literature DB >> 12817919

Cognitive function after anaesthesia in the elderly.

Alex Y Bekker1, Edwin J Weeks.   

Abstract

Despite advances in peri operative care, a significant percentage of elderly patients experience transient post operative delirium and/or long-term post-operative cognitive dysfunction (POCD). This chapter reviews the aetiology, clinical features, preventive strategies and treatment of these syndromes. Pre-operative, intra-operative, and post-operative risk factors for delirium and POCD following cardiac and non-cardiac surgery are discussed. It is most likely that the aetiology of delirium and POCD is multifactorial and may include factors such as age, decreased pre-operative cognitive function, general health status and, possibly, intra-operative events. Currently there is no single therapy that can be recommended for treating post-operative cognitive deterioration. Primary prevention of delirium and POCD is probably the most effective treatment strategy. Several large clinical trials show the effectiveness of multicomponent intervention protocols that are designed to target well-documented risk factors in order to reduce the incidence of post-operative delirium and, possibly, POCD in the elderly.

Entities:  

Mesh:

Year:  2003        PMID: 12817919     DOI: 10.1016/s1521-6896(03)00005-3

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  47 in total

1.  The effects of isoflurane and desflurane on cognitive function in humans.

Authors:  Bin Zhang; Ming Tian; Yu Zhen; Yun Yue; Janet Sherman; Hui Zheng; Shuren Li; Rudolph E Tanzi; Edward R Marcantonio; Zhongcong Xie
Journal:  Anesth Analg       Date:  2011-11-10       Impact factor: 5.108

2.  Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment.

Authors:  Richard P Kline; Elizabeth Pirraglia; Hao Cheng; Susan De Santi; Yi Li; Michael Haile; Mony J de Leon; Alex Bekker
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

Review 3.  Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Horm Behav       Date:  2012-02-18       Impact factor: 3.587

Review 4.  Postoperative delirium and cognitive dysfunction.

Authors:  S Deiner; J H Silverstein
Journal:  Br J Anaesth       Date:  2009-12       Impact factor: 9.166

5.  The effects of depth of isoflurane anesthesia on the performance of mice in a simple spatial learning task.

Authors:  Ana M Valentim; Heber C Alves; I Anna S Olsson; Luís M Antunes
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

6.  Clinical pattern of fungal balls in the paranasal sinuses: our experience with 70 patients.

Authors:  Min Young Seo; Seung Hoon Lee; Gwanghui Ryu; Sang Duk Hong; Hyo Yeol Kim; Hun-Jong Dhong; Seung-Kyu Chung
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-03       Impact factor: 2.503

Review 7.  [Pharmacological peculiarities and problems with older patients].

Authors:  C D Kratz; A Schleppers; T Iber; G Geldner
Journal:  Anaesthesist       Date:  2005-05       Impact factor: 1.041

8.  Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection.

Authors:  Ruth M Barrientos; Matthew G Frank; Amy M Hein; Emily A Higgins; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Brain Behav Immun       Date:  2008-07-11       Impact factor: 7.217

9.  Psychiatric Profile of Retinal Detachment Surgery under Regional Block.

Authors:  Emad Abboud; Afaf Mansour; Waleed Riad
Journal:  Middle East Afr J Ophthalmol       Date:  2008-01

10.  The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming.

Authors:  Laura K Fonken; Matthew G Frank; Meagan M Kitt; Heather M D'Angelo; Diana M Norden; Michael D Weber; Ruth M Barrientos; Jonathan P Godbout; Linda R Watkins; Steven F Maier
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.